.png)
Somewhere in a cardiac device clinic right now, a technician is working through a queue of alerts.
Some will turn out to be clinically significant. Most won't. But every one of them has to be reviewed, because the one that gets missed is the one that matters.
Cardiac monitoring services exist to close the gap between a patient's heart and the clinician responsible for it.
Over the past two decades, the technology has advanced dramatically: monitors are smaller, smarter, and capable of transmitting continuous data from virtually anywhere.
The CIED market alone is projected to grow from $39 billion in 2025 to over $72 billion by 2034 — a trajectory that reflects just how central these devices have become to modern cardiac care.
But the volume of information that technology generates has grown just as fast — and in many programs, faster than the clinical infrastructure built to manage it.
For the electrophysiologists and cardiologists managing these programs, understanding what cardiac monitoring services are, how they work, and where the field is headed is the foundation for making better decisions — about patient care, and about how their teams spend their time.
The Role of Cardiac Monitoring in Modern Patient Care
Cardiac monitoring has always been about one thing: catching what a snapshot misses.
A 12-lead ECG taken in a clinic captures ten seconds of electrical activity. For patients with intermittent arrhythmias, syncope of unknown origin, or implanted devices requiring ongoing surveillance, ten seconds is rarely enough.
Remote and ambulatory monitoring changed that calculus.
By extending the observation window from seconds to days, weeks, or years, cardiac monitoring services give clinicians access to the kind of longitudinal data that in-office visits simply can't produce, and that often makes the difference between a diagnosis and a dead end.
Why Continuous Monitoring Matters for Arrhythmia Management
Arrhythmias are, by nature, unpredictable. Atrial fibrillation may be asymptomatic.
Ventricular tachycardia may resolve before a patient reaches the ED. Without continuous monitoring, clinically significant events go undocumented — and undocumented events don't get treated.
Continuous monitoring closes that gap. It creates an unbroken record of cardiac activity that clinicians can interrogate after the fact, correlate with patient-reported symptoms, and use to guide therapy decisions with confidence rather than inference.
The Shift from In-Clinic to Remote Cardiac Monitoring
For most of cardiology's history, meaningful monitoring happened in a hospital or clinic. Patients were tethered to bedside telemetry, their data reviewed by staff on-site. That model worked — until patient volumes grew, device adoption expanded, and the math stopped adding up.
Remote cardiac monitoring decoupled data collection from physical presence. Patients wear or carry monitoring devices in their daily lives; data transmits automatically to clinical teams who review it off-site.
For programs managing hundreds or thousands of device patients, that shift wasn't just a convenience, it was a structural necessity.
The 2023 Heart Rhythm Society consensus statement on remote device clinics acknowledged the risks directly, citing alert burden, potential for inappropriate clinical management, and staff burnout as consequences of scaling remote monitoring without adequate infrastructure.
Types of Cardiac Monitoring Services
Not all cardiac monitoring is the same. The right modality depends on what a clinician is looking for, how long they need to look, and what level of intervention is warranted if something is found. Here's how the major categories break down.
Holter Monitors
- Worn externally for 24 to 48 hours, with extended-wear versions up to 14 days
- Continuously records every heartbeat and stores data for later analysis
- Best suited for patients with frequent symptoms where short-term, high-fidelity capture is the priority
- Key limitation: if the event doesn't occur during the wear period, it won't be captured
Cardiac Event Monitors
- Worn for up to 30 days
- Most rely on patient activation — the patient triggers a recording when symptomatic; some include auto-detection for rhythm abnormalities
- Key limitation: only as useful as the patient's ability to recognize and respond to symptoms in the moment
Mobile Cardiac Telemetry (MCT)
- Worn for up to 30 days
- Records continuously and transmits data in real time to a monitoring center staffed around the clock
- Clinically significant findings trigger immediate physician notification
- Best suited for patients where timely intervention is a priority
Implantable Loop Recorders (ILRs)
- Inserted just beneath the skin; monitors continuously for up to three to five years
- Particularly valuable for unexplained syncope, cryptogenic stroke workups, and suspected paroxysmal arrhythmias that elude shorter monitoring windows
- Data transmits automatically, flagging detected events for clinical review
Remote Monitoring for Implanted Devices
- Covers pacemakers, ICDs, and CRT devices
- Every interrogation generates data on arrhythmia burden, therapy delivery, lead integrity, and battery status
- Managing that data at scale, across a panel of hundreds or thousands of device patients, is where remote monitoring programs live or die.
- A 2025 analysis of over 6,500 CIED patients found that scheduled transmissions — the majority of which require no clinical action — accounted for more than half of all remote monitoring volume, pointing to a significant opportunity to shift toward alert-based approaches.
How Cardiac Monitoring Data Gets from Patient to Clinician
The technology that captures cardiac data has never been more sophisticated.
But capture is only half the equation.
What happens between the moment a device records an event and the moment a clinician acts on it determines whether that sophistication translates into better patient care — or just more data.
Transmission, Alerts, and the Clinical Workflow
Most modern remote monitoring platforms follow a similar basic workflow. Devices transmit data — either continuously, on a schedule, or when triggered by a detected event — to a manufacturer or third-party monitoring platform. That platform processes the data, applies detection algorithms, and generates alerts for clinician review. Those alerts land in a queue, where they're triaged, reviewed, and acted on by device clinic staff.
In a well-functioning program, the chain from transmission to clinical action is fast, accurate, and manageable. In practice, it rarely stays that way as programs scale.
The Alert Volume Problem: What Happens When Data Outpaces Capacity
Every device patient on a remote monitoring program is a potential source of alerts.
Research published in JACC Advances found that across 140 U.S. device clinics, the majority of ICM alerts were nonactionable — dismissed by technicians and never forwarded to a clinician for review.
Multiply that across a panel of hundreds or thousands of patients, each generating transmissions on their own schedule, each flagged by algorithms that prioritize sensitivity over specificity, and the volume adds up quickly.
The result is a clinical inbox that never empties. Technicians and nurses spend significant portions of their day sorting clinically actionable alerts from noise. Physicians field escalations that may or may not warrant their attention.
And somewhere in that volume, the alerts that genuinely matter risk getting buried. Scaling remote monitoring without scaling the intelligence layer on top of it is where most programs hit a wall. The clinical consequences of that gap are well documented.
The Role of AI in Cardiac Monitoring Services
The data problem in cardiac monitoring isn't going away on its own.
Device adoption is growing, patient panels are expanding, and the volume of transmissions clinical teams are expected to manage continues to climb. The question facing most programs today isn't whether to incorporate AI into their monitoring workflow — it's how.
How AI Triage Is Changing the Way Teams Manage Device Data
AI-powered triage applies machine learning to the alert queue, analyzing incoming transmissions and ranking them by clinical urgency before a human ever looks at them.
Rather than presenting every alert with equal weight, an intelligent triage layer surfaces what needs immediate attention, flags what can wait, and filters out what doesn't require action at all.
The practical effect for clinical teams is significant. Technicians spend less time sorting and more time on the alerts that warrant careful review. Physicians receive escalations that have already been filtered for relevance. And the risk of a high-priority finding getting lost in a crowded queue decreases substantially.
Human-Guided AI vs. Fully Automated Monitoring
The most effective AI implementations in cardiac monitoring aren't designed to replace clinical judgment — they're designed to protect it.
A fully automated system that acts on data without human review introduces its own risks: missed context, algorithm edge cases, liability exposure. What the best programs are building instead is a human-guided model, where AI handles the volume and clinicians handle the decisions.
That distinction matters for how programs evaluate monitoring technology. The goal isn't automation for its own sake. It's giving skilled clinicians the conditions they need to do their best work — with the right information, at the right time, without the overhead of sorting through everything that doesn't need their attention.
What to Look for in a Cardiac Monitoring Service
Choosing a cardiac monitoring service, or evaluating the infrastructure already in place, requires looking beyond device specs and transmission protocols. The clinical and operational performance of a monitoring program depends as much on what happens to the data as on how it's collected.
Clinical Accuracy and Alert Reliability
Alert reliability is the foundation everything else is built on. A monitoring service that flags excessive false positives erodes clinical trust over time. Teams learn to discount alerts, and the ones that matter start to get treated like the ones that don't.
Conversely, a service with poor sensitivity risks missing events that should have triggered action.
The right question isn't how many alerts a service flags. It's how many of those alerts are actionable, and how consistently the system surfaces the right findings at the right time.
Workflow Integration and Team Burden
A monitoring service that operates in isolation from a clinic's existing workflow creates friction at every touchpoint. Staff toggle between platforms. Data lives in one system, documentation in another. Escalation paths are manual and inconsistent.
The programs that manage device patient panels most effectively treat workflow integration as a clinical requirement, not a technical afterthought. That means seamless connectivity with the EHR, clear escalation protocols, and a triage layer that fits the way the team actually works.
Programs that have made that shift, such as Lehigh Valley Heart and Vascular Institute, are seeing measurable results.
Scalability Across a Growing Patient Population
A monitoring program that functions well at 200 patients may struggle significantly at 800.
The bottlenecks that are manageable at a smaller scale tend to compound as clinics grow, and faster than most programs anticipate. Alert volume, staff capacity, transmission backlogs: these are manageable friction points early on that become structural problems later.
Scalability means the infrastructure, the staffing model, and the intelligence layer all grow together. Programs that build for where they are today often find themselves rebuilding sooner than expected. Clinics that have scaled successfully share a few traits in common.
The Future of Cardiac Monitoring
The core purpose of cardiac monitoring has never changed: get the right information to the right clinician in time to make a difference.
What's changing is the scale at which that has to happen, and the tools available to make it possible.
Smarter Triage, Better Outcomes
The next phase of cardiac monitoring isn't about collecting more data.
Programs already have more data than most clinical teams can effectively process. The opportunity is in making that data more useful, faster.
AI triage, intelligent prioritization, and workflow-integrated platforms are moving from differentiators to baseline expectations.
Octagos’ Atlas AI, for example, is built to surface what matters, filter what doesn't, and integrate into existing clinical workflows rather than adding to them.
For patients, smarter triage means fewer delays between a detected event and a clinical response. For care teams, it means spending their expertise where it actually matters rather than on work that algorithms can handle reliably. Those outcomes compound over time, across patient panels, across health systems.
Where the Industry Is Headed
Remote monitoring volumes will keep growing.
Device indications are expanding, implant rates are rising, and patient expectations around continuous care are shifting. The programs best positioned for that future are the ones treating monitoring as an integrated clinical function rather than an administrative one.
That means investing in infrastructure that scales, triage tools that improve with use, and workflows built around how clinical teams actually operate. The technology to do this exists.
The question for most programs is how quickly they move from recognizing the need to acting on it.
Ready to See What Smarter Monitoring Looks Like?
Cardiac device clinics are managing more patients, more transmissions, and more alerts than ever before. The teams doing it well aren't working harder. They have better infrastructure.
Octagos reduces alert burden by 65%, automates routine tasks, and ensures critical cases are reviewed within the hour, so your clinical team can focus on the patients who need them most.
If your team is spending more time managing a queue than caring for patients, it might be time for a different approach.
See How Octagos Works for Nurses